Godel Tim, V Cossel Katharina, Friedrich Reinhard E, Glatzel Markus, Canaan-Kühl Sima, Duning Thomas, Kronlage Moritz, Heiland Sabine, Bendszus Martin, Muschol Nicole, Mautner Victor-Felix
Department of Neuroradiology, Neurological University Clinic, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany.
Department of Pediatrics, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246 Hamburg, Germany.
Diagnostics (Basel). 2020 Nov 30;10(12):1027. doi: 10.3390/diagnostics10121027.
Background The purpose of this study is to examine alterations of the peripheral nervous system (PNS) in oligo-symptomatic patients carrying the Fabry related -gene variant p.A143T by Magnetic Resonance Neurography (MRN) and skin biopsy. This prospective study assessed dorsal root ganglia (DRG) volume L3 to S2, vascular permeability of the DRG L5, S1, and the spinal nerve L5 in five patients carrying p.A143T in comparison to patients with classical Fabry mutations and healthy controls. Moreover, skin punch biopsies above the lateral malleolus of the right foot were obtained in four patients and intraepidermal nerve fiber density (IENFD) was counted individually. Compared to controls, DRG volumes of p.A143T patients were enlarged by 30% (L3, < 0.05), 35% (L4, < 0.05), 29% (L5, = 0.15), 36% (S1, < 0.01), and 18% (S2, < 0.05), but less pronounced compared to patients carrying a classical Fabry mutation. Compared to healthy controls, vascular permeability was decreased by 40% (L5 right), 49% (L5 left), 48% (S1 right), and 49% (S1) ( < 0.01- < 0.001), but non-significant less than patients carrying a classical Fabry mutation. Compared to sex-matched 5% lower normative reference values per decade, IENFD was decreased in three of four patients. MRN and determination of IENFD is able to detect early alteration of the PNS segment in oligo-symptomatic patients with the disease-modifying -variant p.A143T on an individual basis. This procedure might also help in further -variants of uncertain significance for early identification of patients with single major organ manifestation.
背景 本研究的目的是通过磁共振神经成像(MRN)和皮肤活检,检查携带法布里相关基因变异p.A143T的寡症状患者外周神经系统(PNS)的改变。这项前瞻性研究评估了5例携带p.A143T的患者与经典法布里突变患者及健康对照相比,L3至S2背根神经节(DRG)的体积、L5、S1背根神经节以及L5脊神经的血管通透性。此外,对4例患者进行了右脚外踝上方的皮肤打孔活检,并单独计数表皮内神经纤维密度(IENFD)。与对照组相比,p.A143T患者的DRG体积分别增大了30%(L3,<0.05)、35%(L4,<0.05)、29%(L5,=0.15)、36%(S1,<0.01)和18%(S2,<0.05),但与携带经典法布里突变的患者相比,变化不太明显。与健康对照相比,血管通透性降低了40%(L5右侧)、49%(L5左侧)、48%(S1右侧)和49%(S1)(<0.01-<0.001),但比携带经典法布里突变的患者降低程度不显著。与每十年降低5%的性别匹配正常参考值相比,4例患者中有3例的IENFD降低。MRN和IENFD测定能够在个体水平上检测携带疾病修饰变异p.A143T的寡症状患者PNS节段的早期改变。该方法也可能有助于对意义不确定的其他变异进行早期识别单一主要器官表现的患者。